Industry Leaders Gather Next Week to Discuss Paediatric Clinical Trials

Paediatric Clinical Trials
Paediatric Clinical Trials
Spread the Word
Listed Under

* Paediatric
* Pediatric
* Clinical Trials
* Children
* Medicine

* Health
* Medical

* London City - London, Greater - UK

LONDON - March 26, 2014 - PRLog -- Industry leaders will gather next week at the 14th annual conference on Paediatric Clinical Trials to identify cutting-edge developments including innovative ideas for rare diseases, latest advances in cardiology drug development in children, new methods for clinical studies in paediatrics and model-based paediatric drug development.

This year's summit will spotlight on key focus sessions such as global paediatric legislations, PIP submission, facilitating clinical research, patient recruitment, formulation, dosing and extrapolation.

The agenda will feature case study driven presentations from a line-up of industry specialists such as Lundbeck, Astelles, Hoffmann-La Roche, and PPD Consulting.

So far, a snap shot of confirmed attendees include:

Agence Francaise De Securite Sanitaire Des Produits De Sante
Austrian Agency for Health and Food Safety
Bayer Pharma AG
Consortium for Biological and Pharmacological Evaluations (CVBF)
Emerald Lake Ltd
Empowering Children | Enabling Research
F. Hoffmann-La Roche
Ghent University Hospital
GRiP Network of Excellence
HB Clinical
Jenny Walsh Consulting
Klausrose Consulting
L2D consulting
Medicines for Children Research Network (MCRN)
Medimmune LLC
Novartis Vaccines
Opsona Therapeutics Ltd
Paediatric Research Consultancy
PPD Inc.
Prince Sultan Military Medical City
Roche Pharmaceuticals
Sanofi Pasteur MSD Ltd
Svabhegy Paediatric Hospital
UCL, Great Ormond Street Hospital
University of Copenhagen

Event highlights will include keynote address on: How does FDASIA change the regulatory landscape for paediatric drug development in the US, hosted by Christina Bucca-Rechtweg, Head Maternal & Paediatric Regulatory Policy at Novartis. The presentation will discuss:

The Paediatric Study Plan (PSP) as a tool to encourage early paediatric research
A new approach toward considerations for an overarching paediatric program development plan
Non-compliance in post FDASIA environment
An opportunity for global harmonisation

Registration will be closing soon. For those who are interested in attending or downloading an event brochure visit

The Kensington Close Hotel
London UK

About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at

Teri Arri
Source:SMi Group
Email:*** Email Verified
Tags:Paediatric, Pediatric, Clinical Trials, Children, Medicine
Industry:Health, Medical
Location:London City - London, Greater - United Kingdom
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Daily News
Weekly News

Like PRLog?
Click to Share